ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
International Journal of Medicinal Mushrooms
インパクトファクター: 1.423 5年インパクトファクター: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN 印刷: 1521-9437
ISSN オンライン: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v11.i4.40
pages 375-382

Liperoxidation and Cyclooxygenase Enzyme Inhibitory Compounds from the Lipophilic Extracts of Some Culinary-Medicinal Higher Basidiomycetes Mushrooms

Thushara Diyabalanage
Bioactive Natural Products and Phytoceuticals, Department of Horticulture and National Food Safety and Toxicology Center, Michigan State University, East Lansing, MI 48824
VANISREE MULABAGAL
AUBURN UNIVERSITY,Bioactive Natural Products and Phytoceuticals, Department of Horticulture and National Food Safety and Toxicology Center, Michigan State University, East Lansing, MI 48824
Gary Mills
Diversified Natural Products, Inc., Scottville, MI 49454
David L. DeWitt
Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824
Muraleedharan Nair
Michigan State University

要約

We have determined the bioactive constituents in the higher Basidiomycetes edible mushrooms Pholiota nameko, Lentinus edodes, and Pleurotus ostreatus using in vitro lipid peroxidation (LPO) and cyclooxygenase enzyme (COX) inhibitory assays. Ethyl acetate extract of nameko was the most active against LPO, with an inhibition value of 81% at 250 μg/mL. Shiitake and oyster mushroom extracts inhibited LPO by 39% and 52%, respectively, at 250 μg/mL. In the COX assay, the ethyl acetate extracts of nameko, shiitake, and oyster mushrooms inhibited COX-1 and -2 enzymes by 39%, 34%, and 54% and 87%, 92%, and 75%, respectively, at 250 μg/mL. A bioassay-guided purification yielded linoleic acid (1), ergosterol (2), ergosterol peroxide (3), and a glycosphingolipid (4) along with a glyceride fraction (GF), as confirmed by spectroscopic methods. All three mushrooms have shown the presence of compounds 1 and 3 as common constituents. Compound 2 was isolated from both nameko and shiitake mushrooms. Compound 4 was isolated from shiitake and oyster mushrooms. The GF obtained from oyster mushrooms inhibited LPO by 92% and COX-1 and -2 enzymes by 43% and 92%, respectively, at 25 μg/mL.


Articles with similar content:

Assessment of Anti-inflammatory, Lipid Peroxidation and Acute Toxicity of Extracts Obtained From Wild Higher Basidiomycetes Mushrooms Collected From Akure (Southwest Nigeria)
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 6
Antonio Nieto-Camacho, Victor O. Oyetayo, Baldomero Esquivel Rodriguez, Manuel Jimenez
Antibacterial and Anti-Inflammatory Activities of Mycelia of a Medicinal Mushroom from Taiwan, Taiwanofungus salmoneus (Higher Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 1
Shen-Shih Chiang, Jeng-Leun Mau, Shin-Yu Chen, Li-Ting Wang
Antibacterial Activity of Steroidal Compounds Isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) Fruit Body
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 4
Rodrigo S. Cuneo, Artur Smania, Jr., Franco Delie Monache, Elza de Fatima Albino Smania
Influence of Navisporus floccosus (Higher Basidiomycetes) n-Hexane Extract on Arachidonate Metabolism in Vitro
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 5
Sabine Ortmann, Vivian Leliebre-Lara, Clara Nogueiras Lima, Ute Widowitz, Eva-Maria Pferschy-Wenzig, Rudolf Bauer
In Vitro Assessment of Extracts of the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) Against Different Plant Pathogenic Fungi
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 4
Mirza Nabeel Baig, Ahmad Ali Shahid, Muhammad Ali